tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Technical Analysis

95 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Petros Pharmaceuticals’s (PTPI) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Petros Pharmaceuticals is a Sell.
Petros Pharmaceuticals’s (PTPI) 20-Day exponential moving average is 0.46, while Petros Pharmaceuticals’s (PTPI) share price is $0.401, making it a Sell.
Petros Pharmaceuticals’s (PTPI) 50-Day exponential moving average is 0.59, while Petros Pharmaceuticals’s (PTPI) share price is $0.401, making it a Sell.

Petros Pharmaceuticals (PTPI) Pivot Points

Jul 08, 2024, 04:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.36
0.38
0.40
0.42
0.44
0.46
0.48
Fibonacci
0.38
0.40
0.40
0.42
0.43
0.44
0.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Petros Pharmaceuticals (PTPI) Moving Averages

Jul 08, 2024, 04:22 PM
Period
Simple
Exponential
MA5
0.43Sell
0.43Sell
MA10
0.44Sell
0.44Sell
MA20
0.45Sell
0.46Sell
MA50
0.55Sell
0.59Sell
MA100
0.93Sell
0.84Sell
MA200
1.16Sell
1.29Sell
Petros Pharmaceuticals’s (PTPI) 10-Day exponential moving average is 0.44, while Petros Pharmaceuticals’s (PTPI) share price is $0.401, making it a Sell.
Petros Pharmaceuticals’s (PTPI) 100-Day exponential moving average is 0.84, while Petros Pharmaceuticals’s (PTPI) share price is $0.401, making it a Sell.
Petros Pharmaceuticals’s (PTPI) stock price is $0.401 and Petros Pharmaceuticals’s (PTPI) 50-day simple moving average is 0.55, creating a Sell signal.
Petros Pharmaceuticals’s (PTPI) stock price is $0.401 and Petros Pharmaceuticals’s (PTPI) 100-day simple moving average is 0.93, creating a Sell signal.
Petros Pharmaceuticals’s (PTPI) stock price is $0.401 and Petros Pharmaceuticals’s (PTPI) 200-day simple moving average is 1.16, creating a Sell signal.

Petros Pharmaceuticals (PTPI) Technical Indicators

Jul 08, 2024, 04:22 PM
Name
Value
Implied Action
RSI (14)
38.67
Neutral
STOCH (9,6)
21.50
Neutral
STOCHRSI (14)
25.48
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
13.96
Buy
Williams %R
-72.87
Buy
CCI (14)
-72.41
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
40.87
Neutral
ROC
-8.70
Sell
Petros Pharmaceuticals’s (PTPI) Relative Strength Index (RSI) is 38.67, creating a Neutral signal.
Petros Pharmaceuticals’s (PTPI) Trend Strength Indicator (ADX) is 13.96, creating a Buy signal.
Petros Pharmaceuticals’s (PTPI) Commodity Channel Index (CCI) is -72.41, creating a Neutral signal.
Petros Pharmaceuticals’s (PTPI) Price Rate of Change (ROC) is -8.70, creating a Sell signal.

FAQ

Is PTPI a Buy, Hold, or Sell?
Based on PTPI’s technical indicators, PTPI is a Strong Sell.
    What is PTPI’s RSI (14)?
    PTPI’s RSI (14) is 38.67, which suggests PTPI is a Neutral.
      What is PTPI’s MACD?
      PTPI’s MACD is -0.04, which suggests PTPI is a Sell.
        What is PTPI’s 5-day moving average?
        PTPI’s 5-day moving average is 0.43, which suggests PTPI is a Sell.
          What is PTPI’s 20-day moving average?
          PTPI 20-day moving average is 0.45, which suggests PTPI is a Sell.
            What is PTPI’s 50-day moving average?
            PTPI’s 50-day moving average is 0.55, which suggests PTPI is a Sell.
              What is PTPI’s 200-day moving average?
              PTPI’s 200-day moving average is 1.16, which suggests PTPI is a Sell.
                What is PTPI’s Williams % R (14)?
                PTPI’s Williams % R (14) is -72.87, which suggests PTPI is a Buy.
                  What is PTPI’s CCI (14)?
                  PTPI’s CCI (14) is -72.41, which suggests PTPI is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis